Resources

Causality and Program Evaluation

• Differences-in-Difference design, Health Care Policy Science Lab

• Methods Articles Health Care Policy Science Lab

• Hernán MA, Robins JM. Causal Inference: What If.

• Causal Inference: The Mixtape, by Scott Cunningham

• Causal Graphs explained by Nick Huntington Klein helps to gain an intuitive understanding of identifying causal effects from non-experimental data, more resources provided

Social science research methods

• Health Services Research methods corner provides many resources for program evaluation, econometrics and qualitative research

Reproducible research & open science

• A guide to Reproducibility in Science

• The Open Science Training Handbook

• Data and Code Guidance by Data Editors

• Uri Simonshon caters 8 tips to make open research more findable and accessible

• Michael Shill provides tips to produce legible and reprodrucible do-files in Stata

• Cornell University caters a guide to generate a Readme file to document the meta data of a project.

Data - Pharmaceutical markets

Pharmaceutical reference data bases

These data bases help to identify active ingredients by different classifications, all of which are freely available.

• WHO ATC Index helps to find active pharmaceutical ingredients by the ATC classification

• German ATC Index

• Drugbank.com allows finding and classifying drugs by a large variety of criteria including the ATC classification, marketing authorization data for the United States (FDA), Canada and the European Union (EMA), a public use file is available for download if you register your research project.

• DrugCentral provides comprehensive data about chemical and pharmacological features of pharmaceuticals as well as marketing authorization data.

• RxNorm is the US National Library’s compedium linking different vocabularies that document drugs. You may browse it via RxNav

• Swiss Pharmaceutical Reference Database - Spezialitätenliste, is freely available for download

• German pharmaceutical reference databases are behind paywalls, or for scientific research use that requires registration of a research project

  • WIDO GKV Arzneimittelindex / German Drug Index
  • ABDATA Pharma Daten Service

Drug shortages

• Drug shortages in Switzerland provided by Enea Martinelli

HTA and value based decision-making

• Early assessments of health benefit based on AMNOG (Arzneimittelmarktneuordnungsgesetz) in Germany

  • Comprehensive data of benefit assessments is provided in XML format from GBA, currently includes decisions starting from 2020, but will be updated steadily to cover all assessments starting from 2011.
  • As part of a project funded by the German Research Foundation, I provide data from the first years that AMNOG was in effect
  • DAK AMNOG Report 2020, annual report of AMNOG decisions
  • Innovationsreport Techniker Krankenkasse is an annual report about the quality of pharmaceutical care

Pharmaceutical market in Germany - all resources are in German only

• Zi Trendbericht provides developments of prescription pharmaceuticals in Germany

• Arzneiverordnungsreport is the annual report of the Germany pharmaceutical market based on GKV-Arzneimittelindex für ambulante Patienten (Statutory Health Insurance Pharmaceutical Index for patients in ambulatory care), provided by AOK-Bundesverband, see the 2020 Edition here.

• Barmer Krankenkasse provides an annual report of the pharmaceutical market

• WIP provides a report for pharmaceutical care in the privately insured

• Reference Prices - Festbeträge

Data - Physicians

• US National Ambulatory Medical Care Survey (NAMCS) has public use files on physician level